Company Profile
Myomo Stock Price, News & Catalysts
- Ticker:
- MYO
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.61 USD (+3.21%)
Close
Last updated: October 1, 2026
41M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, MYO closed up 3.21% at $1.61. No new same-company headline was identified in the current news window.
Company overview
Powered Orthotics Company
Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions.
MyoPro Product Family
MyoPro detects weak electrical signals from a user's muscles and translates them into powered movement at the elbow, wrist, or hand. Each orthosis is customized to the patient's anatomy and functional needs.
Neuromuscular Patient Population
The device is used by people with upper-limb weakness resulting from stroke, brachial plexus injury, spinal cord injury, multiple sclerosis, and other conditions. Candidates typically retain enough muscle signal to control the powered brace.
Direct-to-Patient Model
Myomo markets directly to prospective users, conducts remote or in-person screening, and works with clinicians and orthotics professionals to complete evaluation and fitting. Patient advocacy and digital lead generation are important to demand creation.
Reimbursement and Fabrication
Revenue depends on insurance authorization and payment, including Medicare and commercial plans. Centralized fabrication, clinical documentation, and claims support help move qualified patients from evaluation to delivery.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Myomo (MYO)?
Myomo (MYO) most recently closed at 1.61 USD, a +3.21% move versus the previous session.
What is the market cap of Myomo (MYO)?
Myomo currently has a market capitalization of 41M USD on BioPharmSignal.
What does Myomo do?
Powered Orthotics Company Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions. MyoPro Product Family MyoPro detects weak electrical signals from a user's muscles and translates them into...
On which exchange is MYO stock listed?
Myomo (MYO) is associated with NYSE, United States, Biopharma.
What is Powered?
Powered Orthotics Company Myomo develops wearable robotic orthoses for people with impaired arm and hand function.
Which conditions is Myomo targeting with Powered?
Powered Orthotics Company Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions. MyoPro Product Family MyoPro detects weak electrical signals from a user's muscles and translates them into...
What is Orthotics?
Powered Orthotics Company Myomo develops wearable robotic orthoses for people with impaired arm and hand function.
What is Myomo?
Powered Orthotics Company Myomo develops wearable robotic orthoses for people with impaired arm and hand function.